Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acid Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112979645B reveals a novel Lewis acid-catalyzed route for indolizine derivatives, offering significant cost reduction and green chemistry benefits for API manufacturing.
Novel solvent-free method reduces cost and improves safety for pharmaceutical intermediate manufacturing supply chains globally.
Novel green synthesis route for Beclomethasone dipropionate intermediates offering high purity >99.5% and reduced wastewater for pharmaceutical manufacturing.
Patent CN101891677B reveals a green 2-step route to Mexidole using solid superacids. Achieve high purity and cost reduction in API manufacturing with scalable technology.
Novel patent CN105461671B enables cost-effective high-purity intermediate production with simplified supply chain and scalable manufacturing processes for global buyers.
Efficient Lewis acid catalyzed synthesis of Marmycin A derivatives. High regioselectivity and yield for pharmaceutical intermediates targeting topoisomerase inhibition.
Patent CN113620876B details a high-yield synthesis route for 5-methoxy laudanosine offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN108047172B details a novel catalytic method for converting biomass-based levulinic acid into high-purity pharmaceutical intermediates with improved yield.
Patent CN108358793B details a green one-pot synthesis of secondary amines from alkynes, offering significant cost reduction in API manufacturing without metal catalysts.
Novel low-temperature catalytic route for D-penicillamine enhances yield and purity. Ideal for pharmaceutical intermediate suppliers seeking cost reduction and scalable production solutions.
Patent CN114394913A reveals a metal-free heteropoly acid catalytic route for oxime ether derivatives, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover a novel Lewis acid-catalyzed method for conjugated diene synthesis from patent CN114671850A. Achieve cost reduction in fine chemical manufacturing with mild, scalable conditions.
Patent CN112299962B reveals a novel supported chiral phosphoric acid catalyst for high-yield citral intermediate synthesis, offering significant cost reduction and supply chain reliability.
Novel solid acid catalysis method for Vitamin K1 ensures high purity and green manufacturing. Ideal for reliable vitamin K1 supplier partnerships seeking cost reduction.
Novel SnCl2/oxidant system enables high-yield Povarov reaction with aliphatic aldehydes, offering cost-effective pharma intermediate manufacturing.
Patent CN113336792A reveals a novel Lewis acid-catalyzed synthesis for cyclic phosphonates, offering superior stereoselectivity and yield for pharmaceutical manufacturing.
Patent CN1205196C reveals a novel C(10) selective acylation method for 10-DAB. Discover cost-effective taxane intermediate manufacturing and supply chain advantages.
Patent CN102146097A reveals a solvent-free DOPO synthesis route. Achieve >99% purity with reduced equipment costs for polymer additive manufacturing.
Patent CN103880784A details a green synthesis for cis-6,7-epoxy-(z,z)-3,9-octadecadiene using heteropoly acid catalysts. Discover cost-effective manufacturing strategies.
Patent CN116040592A reveals a novel LiFSI preparation method using lithium alloys, offering superior purity and simplified processing for reliable battery electrolyte suppliers.